Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Atria Wealth Solutions Inc. cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,110 shares of the exchange traded fund’s stock after selling 2,438 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in SPDR S&P Biotech ETF were worth $982,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Provident Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after purchasing an additional 300 shares in the last quarter. Garrison Bradford & Associates Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth $39,000. Compass Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after purchasing an additional 200 shares in the last quarter. Golden State Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 319 shares in the last quarter. Finally, Avalon Trust Co purchased a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth $57,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $85.16 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $105.47. The firm has a market capitalization of $4.64 billion, a PE ratio of 11.47 and a beta of 0.97. The stock has a fifty day simple moving average of $85.08 and a two-hundred day simple moving average of $84.01.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.